Tricuspid Regurgitation after Orthotopic Heart Transplantation: Trajectories and Association With Mortality
Clinical Transplantation · 2025
DOI: 10.1111/ctr.70062 ↗At a glance
Journal article in Clinical Transplantation, 2025. Written by Kiran Belani and 9 co-authors. Institution: Department of Anesthesiology, Northwestern Memorial Hospital, Chicago, Illinois, USA. Major MEDLINE topics: Heart Transplantation, Tricuspid Valve Insufficiency, Postoperative Complications. 25 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Background
Tricuspid regurgitation (TR) is common immediately after orthotopic heart transplantation (OHT), though the expected outcomes of TR over time remain undefined. In this study, we examined the natural trajectory of TR in the first 120 days post‐transplantation. We observed the clinical phenotypes of trajectories of TR after OHT, and assessed trajectory correlation with 1‐year mortality and degree of right ventricular (RV) dysfunction.
Methods
All patients who underwent OHT at a single institution from January 2009 to July 2019 were included, unless death occurred during the index hospitalization. TR and RV dysfunction on follow‐up transthoracic echocardiograms were tracked on 4‐point scales and latent‐class mixed modeling (LCMM) identified classes of TR trajectories. Fisher's exact test was used to compare 1‐year mortalities between classes.
Results
Based on LCMM, four distinct classes of TR trajectories emerged, characterized as sustained ( n = 40), variable ( n = 172), stable ( n = 175), and recovered ( n = 189) TR. Significant differences in mortality rates were found amongst classes at 10.0%, 8.1%, 4.0%, and 2.6%, respectively ( p = 0.025). The degree of RV dysfunction mirrored TR severity in all subsets except the sustained TR group.
Conclusions
The trajectory of TR in the first 120 days post‐OHT is associated with 1‐year mortality. In many subsets, there is a close association with TR grade and RV function improvement. However, in the sustained TR group, RV function improved without subsequent improvement in TR severity. These findings could identify patients with higher mortality risk for whom more frequent follow‐up or intervention is warranted.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Anesthesiology, Northwestern Memorial Hospital, Chicago, Illinois, USA.
- Medical Center Anesthesiologists, Des Moines, Iowa, USA.
- Departments of Anesthesiology and Cardiac Surgery, Duke University Medical Center, Durham, North Carolina, USA.
ORCID profiles: Kiran Belani, Vincent Brinker, Negmeldeen Mamoun, Adam DeVore, Madhav Swaminathan, Alina Nicoara
Cite
APA
Belani, K., Brinker, V., Fuller, M., Cooter, M., Schroder, J. N., Mamoun, N., DeVore, A., Swaminathan, M., Nicoara, A., & McCartney, S. L. (2025). Tricuspid Regurgitation after Orthotopic Heart Transplantation: Trajectories and Association With Mortality. Clinical Transplantation. https://doi.org/10.1111/ctr.70062
Vancouver
Belani K, Brinker V, Fuller M, Cooter M, Schroder JN, Mamoun N, et al. Tricuspid Regurgitation after Orthotopic Heart Transplantation: Trajectories and Association With Mortality. Clinical Transplantation. 2025. doi:10.1111/ctr.70062
BibTeX
@article{Belani2025,
author = {Belani, Kiran and Brinker, Vincent and Fuller, Matthew and Cooter, Mary and Schroder, Jacob N and Mamoun, Negmeldeen and DeVore, Adam and Swaminathan, Madhav and Nicoara, Alina and McCartney, Sharon L},
title = {Tricuspid Regurgitation after Orthotopic Heart Transplantation: Trajectories and Association With Mortality},
journal = {Clinical Transplantation},
year = {2025},
doi = {10.1111/ctr.70062}
}
EUVIMED